Issues surrounding clinical trial endpoints in solid malignancies with a focus on metastatic non-small cell lung cancer-Reference-Cited by-同舟云学术

Issues surrounding clinical trial endpoints in solid malignancies with a focus on metastatic non-small cell lung cancer

Published:2012-09 Issue:3 Volume:77 Page:475-481
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Garon Edward B.

Funder

Boehringer Ingelheim Pharmaceuticals Inc. (BIPI)

NIH

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference78 articles.

1. Cancer statistics, 2012;Siegel;CA Cancer J Clin,2012

2. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology™. Non-small cell lung cancer. V.2.2012. http://www.nccn.org/professionals/physician_gls/PDF/nscl.pdf [accessed 28.11.11].

3. Chemotherapy and supportive care versus supportive care alone for advanced non-small cell lung cancer;Non-Small Cell Lung Cancer Collaborative Group;Cochrane Database Syst Rev,2010

4. Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy;Shepherd;J Clin Oncol,2000

5. Polychemotherapy in advanced non small cell lung cancer: a meta-analysis;Souquet;Lancet,1993

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of phase III clinical trials in metastatic NSCLC to assess the correlation between QoL results and survival outcomes;BMC Medicine;2023-07-03

3. Effect of COPD on Inflammation, Lymphoid Functions and Progression-Free Survival during First-Line Chemotherapy in Advanced Non-small Cell Lung Cancer;Pathology & Oncology Research;2019-05-14

4. Trends in endpoint selection and result interpretation in advanced non‐small cell lung cancer clinical trials published between 2000 and 2012: A retrospective cohort study;Thoracic Cancer;2019-03-13

5. Treatment Paradigms for Advanced Non-Small Cell Lung Cancer at Academic Medical Centers: Involvement in Clinical Trial Endpoint Design;The Oncologist;2017-04-13